JPRN-UMIN000006603已完成2 期
A phase II study of S-1/Cisplatin/Trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced and/or recurrent gastric cancer - HOG-GC 01
HOG-GC (Hiroshima oncology group of gastric cancer)0 个研究点目标入组 25 人开始时间: 2011年10月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) history of a previous drug allergy 2) pregnant or nursing patient or with intent to bear baby 3)R1 gastrectomy 4)need continuing use of flucytosine, phenytoin, warfarin potassium 5)Active infection or other inflammatory disease 6)with severe allergy to Trastuzumab, S-1 and cisplatin 7)History of cardiac disease 8)patients with serious concomitant diseas 9)with diarrhea 10)with ascites or pleural effusion 11)with multiple bone metastasis 12)peripheral sensory neuropathy 13)with brain metastasis 14)received operation within 28 days 15)simultaneous or metachronous double cancers 16)with clinically important mental disorder need to treat 17)cannot stopped steroids or immunosuppressing drug 18)Infection with hepatitis B 19)Inappropriate for the trial at the physician's assessment
研究者
相似试验
已完成
2 期
Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)Carcinoma of Unknown Primary SitesJPRN-UMIN000001364Kyushu Medical Oncology Group38
已完成
2 期
A phase II study of cisplatin with TS-1 for patients with cancer of primary unknowJPRN-C000000271Department of Medical Oncology, Kinki University School of Medicine45
已完成
2 期
A randomized phase II study of TS-1+Cisplatin versus Vinorelbine+Cisplatin,with thoracic radiotherapy for locally advanced non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000002420West Japan Oncology Group110
已完成
2 期
A randomized phase II study of cisplatin+TS-1 versus cisplatin+docetaxel, with thoracic radiotherapy for locally advanced non-small cell lung cancer (TORG1018)on-small cell lung cancerJPRN-UMIN000005993Thoracic Oncology Research Group110
招募中
2 期
Phase II trial of S-1 based therapy+/-Trastuzmab combination therapy for unresectable gastric cancerJPRN-UMIN0000060582nd department of internal medicine Tottori University school of medicine30